Angiogenesis and vascular survival ability in ovarian adenocarcinomas

Virchows Archiv

Volumn 445, Issue 5, 2004, Pages 521-526

  Giatromanolaki, A ^a   Sivridis, E ^a   Tsikouras, P ^a   Manavis, I ^a   Maroulis, G ^a   Koukourakis, M I ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Angiogenesis; Ovarian adenocarcinomas; Tumour angiogenic ability; Vascular survival ability

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROGNOSIS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 9944257587     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1089-y     Document Type: Article

References (29)

1. Abulafia O, Ruiz JE, Holcomb K, Dimaio TM, Lee YC, Sherer DM (2000) Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma. Obstet Gynecol 95:548-552
2. Alvarez AA, Krigman HR, Whitaker RS, Dodge RK, Rodriguez GC (1999) The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Clin Cancer Res 5:587-591
3. Brown DL, Doubilet PM, Miller FH, Frates MC, Laing FC, DiSalvo DN, Benson CB, Lerner MH (1998) Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 208:103-110
4. Folkman J (1985) Tumor angiogenesis. Adv Cancer Res 43:175-203
5. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, Harris AL (1993) Relationship of endothelial cell proliferation to tumour vascularity in human breast cancer. Cancer Res 53:4161-4163
6. Gasparini G, Bonoldi E, Viale G, Verderio P, Boracchi P, Panizzoni GA, Radaelli U, Di Bacco A, Guglielmi RB, Bevilacqua P (1996) Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer 69:205-211
7. Giatromanolaki A (2001) Prognostic role of angiogenesis in non-small cell lung cancer. Anticancer Res 21:4373-4382
8. Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC (1997) Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin Cancer Res 3:2485-2492
9. Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Gatter KC, Harris AL (2000) 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 192:140-149
10. Giatromanolaki A, Sivridis E, Minopoulos G, Polychronidis A, Manolas C, Simopoulos C, Koukourakis MI (2002) Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer. Clin Cancer Res 8:1185-1191
11. Giatromanolaki A, Sivridis E, Simopoulos C, Polychronidis A, Gatter KC, Harris AL, Koukourakis MI (2002) Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer. Clin Exp Metastasis 19:673-679
12. Giatromanolaki A, Sivridis E, Koukourakis MI (2004) Tumour angiogenesis: vascular growth and survival. Acta Pathol Micro Immunol Scan (in press)
13. Griffiths JR, McIntyre DJ, Howe FA, Stubbs M (2001) Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. Novartis Found Symp 240:46-62
14. Harfouche R, Hassessian HM, Guo Y, Faivre V, Srikant CB, Yancopoulos GD, Hussain SN (2002) Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res 64:135-147
15. Heimburg S, Oehler MK, Papadopoulos T, Caffier H, Kristen P, Dietl J (1999) Prognostic relevance of the endothelial marker CD34 in ovarian cancer. Anticancer Res 19:2527-2529
16. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ (1995) Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147:33-41
17. Leek RD (2001) The prognostic role of angiogenesis in breast cancer. Anticancer Res 21:4325-4331
18. Liu W, Davis DW, Ramirez K, McConkey DJ, Ellis LM (2201) Endothelial cell apoptosis is inhibited by a soluble factor secreted by human colon cancer cells. Int J Cancer 92:26-30
19. Obermair A, Wasicky R, Kaider A, Preyer O, Losch A, Leodolter S, Kolbl H (1999) Prognostic significance of tumor angiogenesis in epithelial ovarian cancer. Cancer Lett 138:175-182
20. Papadopoulos I, Giatromanolaki A, Koukourakis MI, Sivridis E (2004) Tumour angiogenic activity (TAA) and vascular survival ability (VSA) in bladder carcinoma. J Clin Pathol 57:250-255
21. Saito H, Tsujitani S (2001) Angiogenesis, angiogenic factor expression and prognosis of gastric carcinoma. Anticancer Res 21:4365-4372
22. Sata M, Kakoki M, Nagata D, Nishimatsu H, Suzuki E, Aoyagi T, Sugiura S, Kojima H, Nagano T, Kangawa K, Matsuo H, Omata M, Nagai R, Hirata Y (2000) Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension 36:83-88
23. Scott PA, Gleadle JM, Bicknell R, Harris AL (1998) Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer 75:706-712
24. Sivridis E (2001) Angiogenesis and endometrial cancer. Anticancer Res 21:4383-4388
25. Sivridis E, Giatromanolaki A, Koukourakis MI (2003) The vascular network of tumours - what is it not for? J Pathol. 201:173-180
26. Streeter EH, Crew JP (2001) Angiogenesis, angiogenic factor expression and prognosis of bladder cancer. Anticancer Res 21:4355-4363
27. Subarsky P, Hill RP (2003) The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 20:237-250
28. Thompson WD, Shiach KJ, Fraser RA, McIntosh LC, Simpson JG (1987) Tumour acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol 151:323-332
29. Zachary I (2001) Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol 280:1375-1386